MDACC Study No:2011-0559 ( NCT No: Not Applicable Clinical Trial)
Title:The Role of Tryptophan Metabolism in the Chronic Fatigue Experienced by Chronic Myeloid Leukemia (CML) Survivors
Principal Investigator:Jorge Cortes
Treatment Agent: None
Study Status:Terminated
Study Description:The goal of this research study is to learn more about the quality of life of
patients with CML who receive a TKI. Researchers want to learn if and how the
breakdown of tryptophan (an amino acid found naturally in the body that may be
affected by TKIs) is related to symptoms such as fatigue.
Hide details for General InformationGeneral Information

Disease Group:Leukemia
Phase of Study:N/A
Treatment Agents: None
Treatment Location:Only at MDACC
Estimated Length of Stay in Houston:
Supported By:MDACC IRG
Return Visit:
Home Care:

Hide details for Study Contact InformationStudy Contact Information

Physician Name:Jorge Cortes
For Clinical Trial Enrollment:713-794-5783
For General Questions about Clinical Trials:800-392-1611 (in U.S.A.) 713-792-6161 (outside U.S.A.)

Show details for Study Objectives / OutcomesStudy Objectives / Outcomes
Show details for Study Status InformationStudy Status Information
Show details for Enrollment EligibilityEnrollment Eligibility
Show details for Resources and LinksResources and Links
Show details for ResultsResults